To compare the efficacy of Bevacizumab and clinical features in patients with macular edema following branch retinal vein occlusion startified by baseline visual acuity

Trial Profile

To compare the efficacy of Bevacizumab and clinical features in patients with macular edema following branch retinal vein occlusion startified by baseline visual acuity

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Retinal oedema; Retinal vein occlusion
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top